This week’s 52 in 52 Review

    NextPrevious

    This week’s 52 in 52 Review

    Title: “The 52 in 52 Review: Heparin plus TPA compared to Heparin alone for Submassive PE”

    Article Citation: Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W; Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002 Oct 10;347(15):1143-50. PMID: 12374874

    What we already know about the topic: Alteplase or thrombolysis is indicated therapy in  hemodynamically unstable patients with massive pulmonary embolism (PE). Treatment for submassive hemodynamically stable PE remains controversial. Few studies have demonstrated a risk-benefit ratio for thrombolysis for submassive stable PE.

    Why this study is important: In this study, the authors compare treatment of Heparin plus placebo to Heparin plus thrombolysis in patients with submassive PE to demonstrate  risk vs benefit. This can potentially change practice management of stable submassive PE patients.

    Brief overview of the study: This study is a prospective randomized double blinded placebo-controlled trial. 256 patients were randomized to receive either Heparin and Alteplase or Heparin and placebo. Randomized groups were similar in patient demographic and clinical parameters at baseline. Primary end-point was in hospital death or clinical deterioration which required an escalation in treatment. There was a statistically significant increased incidence of the primary endpoint in the Heparin/Placebo group vs the Heparin/Alteplase group. (24% vs 11%, p = 0.006). Escalation of treatment was also significantly higher in the placebo group as well (24% vs 10%, p = 0.004). Requirement for secondary thrombolysis was again increased in the placebo group (23% vs 9%, p = 0.001). All secondary endpoints; recurrent PE, major bleeding, fatal bleeding, hemorrhagic stroke, were similar in each group without statistical difference.

    Limitations: My primary issues with this study are: (1) A very low (N), 286 patients were randomized to either group which is a small sample size. (2) In hospital mortality rates were uncharacteristically low in this study when compared to the national average for PE by the PE registry (8%), which may have been due to uncovered confounders.  

    Take home points: I believe further large scale multicentered studies are needed to determine the benefit of Alteplase and Heparin for hemodynamically stable sub massive PE patients.

     

    • Welcome! This is the website for the Mount Sinai Emergency Ultrasound Division. It serves as an information resource for residents, fellows, medical students and others seeking information about point-of-care ultrasound. There is a lot ofRead more

    • Difficult placement of an OGT? Try an ET tube introducer

      Tl;dr: Failed OGT placement in an intubated patient is common. Try using an 8.0 ETT as an introducer into the esophagus to prevent coiling in the mouth / upper esophagus.   Placement of an OGTRead more

    • Applying the Pelvic Binder: Pearls and Pitfalls

      Tl;dr: (1) Never rock the pelvis. Firmly squeeze and hold. (2) Consider quickly assessing for rectal or vaginal bleeding prior to binder application as this would suggest an open fx into the vag / rectalRead more

    • Don’t Be Rash

      Do you ever have a patient with a rash you just don’t recognize?  If you’re like me, it happens all the time and it can be hard to organize your differential.  Michelle Lin (https://aliemcards.com/cards/rash-unknown) published a greatRead more

    • Buprenorphine Band Wagon

      Do you know David Cisewski?  He’s incredible and he’s written an incredible review on buprenorphine (http://www.emdocs.net/buprenorphine-where-do-we-stand/) that I’d like to tell you all about. Buprenorphine marketed as Suboxone (but soon to be generic) is a mu-opioid receptor partialRead more

    • Ultrasound and Found

      Ultrasound for kidney stone has always been confusing.  If we do the ultrasound and find no hydro, don’t we need the CT to rule an alternate diagnosis?  If we do the ultrasound and find hydro, don’t weRead more

    • Old Graft? New friend!

      ESRD patients are typically “hard sticks.”   The arm with the fistula is typically off limits (unless in emergency settings) and the other arm is either difficult to access or occasionally has an old fistula. ThisRead more

    • The Supraclavicular Subclavian

      Traditionally, central line placement in the subclavian vein (SCV) involves a landmark-based approach in which the needle is guided under the clavicle. For the U/S lovers, there is an alternative approach to the subclavian inRead more

    • Paper Review: Are we hurting patients via oxygen supplementation?

      Bottom line up front: A recent large, high quality meta-analysis reported a significant mortality effect with the use of liberal, rather than conservative, oxygen supplementation. The number needed harm for 30-day mortality was 1 inRead more

    NextPrevious